Literature DB >> 7989602

Evidence for deactivation of both ectosolic and cytosolic 5'-nucleotidase by adenosine A1 receptor activation in the rat cardiomyocytes.

M Kitakaze1, M Hori, T Minamino, S Takashima, K Komamura, K Node, T Kurihara, T Morioka, H Sato, M Inoue.   

Abstract

Adenosine, an important regulator of many cardiac functions, is produced by ectosolic and cytosolic 5'-nucleotidase. The activity of these enzymes is influenced by several ischemia-sensitive metabolic factors, e.g., ATP, ADP, H+, and inorganic phosphate. However, there is no clear evidence that adenosine itself affects 5'-nucleotidase activity. This study tested whether adenosine decreases the activity of ectosolic and cytosolic 5'-nucleotidase. Cardiomyocytes were isolated from adult male Wistar rats and suspended in the modified Hepes-Tyrode buffer solution. After stabilization, isolated cardiomyocytes were incubated with and without adenosine (10(-9) - 10(-4) M). Ectosolic and cytosolic 5'-nucleotidase activity was decreased by exogenous adenosine (ectosolic 5'-nucleotidase activity, 20.6 +/- 2.3 vs. 8.6 +/- 1.6 mumol/min per 10(6) cells [P < 0.05]; cytosolic 5'-nucleotidase activity, 2.47 +/- 0.58 vs. 1.61 +/- 0.54 mumol/min per 10(6) cells [P < 0.05] at 10(-6) M adenosine) after 30 min. The decrease in ectosolic and cytosolic 5'-nucleotidase activity was inhibited by 8-phenyltheophylline and pertussis toxin, and was mimicked by N6-cyclohexyladenosine, an adenosine A1 receptor agonist. Neither CGS21680C, and A2 receptor agonist, nor cycloheximide deactivated ectosolic and cytosolic 5'-nucleotidase. Thus, we conclude that activation of adenosine A1 receptors is coupled to Gi proteins and attenuates ectosolic and cytosolic 5'-nucleotidase activity in rat cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989602      PMCID: PMC330077          DOI: 10.1172/JCI117613

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

1.  Adenosine as inhibitor of myocardial effects of catecholamines.

Authors:  J Schrader; G Baumann; E Gerlach
Journal:  Pflugers Arch       Date:  1977-11-25       Impact factor: 3.657

2.  An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue.

Authors:  M Honma; T Satoh; J Takezawa; M Ui
Journal:  Biochem Med       Date:  1977-12

3.  Evidence for a continual exchange of 5'-nucleotidase between the cell surface and cytoplasmic membranes in cultured rat fibroblasts.

Authors:  C C Widnell; Y J Schneider; B Pierre; P Baudhuin; A Trouet
Journal:  Cell       Date:  1982-01       Impact factor: 41.582

Review 4.  The role of adenosine in the regulation of coronary blood flow.

Authors:  R M Berne
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

5.  Inhibitory effect of adenosine on adrenergic neuroeffector transmission in the rabbit heart.

Authors:  P Hedqvist; B B Fredholm
Journal:  Acta Physiol Scand       Date:  1979-01

6.  Serum 5'-nucleotidase in patients with tumor in the liver.

Authors:  K Smith; H H Varon; G J Race; D L Paulson; H C Urschel; J T Mallams
Journal:  Cancer       Date:  1966-09       Impact factor: 6.860

7.  A kinetic study of the soluble 5'-nucleotidase of rat liver.

Authors:  G van den Berghe; C van Pottelsberghe; H G Hers
Journal:  Biochem J       Date:  1977-03-15       Impact factor: 3.857

8.  Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes.

Authors:  L Belardinelli; G Isenberg
Journal:  Circ Res       Date:  1983-09       Impact factor: 17.367

Review 9.  Role of adenosine and its interaction with alpha adrenoceptor activity in ischaemic and reperfusion injury of the myocardium.

Authors:  M Kitakaze; M Hori; T Kamada
Journal:  Cardiovasc Res       Date:  1993-01       Impact factor: 10.787

10.  Modulation by islet-activating protein of adenylate cyclase activity in C6 glioma cells.

Authors:  T Katada; T Amano; M Ui
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.